Erscheint 6 Ausgaben pro Jahr
ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502
Indexed in
Triple Negative Breast Cancer: From Molecular Portrait to Therapeutic Intervention
ABSTRAKT
Triple negative breast cancer is a subtype of breast cancer that lacks expression of an estrogen receptor (ER), a progesterone receptor (PR), and HER2. It is characterized by its unique molecular profile, aggressive behavior, and distinct pattern of metastasis. Epidemiological studies show a high prevalence of triple negative breast cancer among younger women and those of African descent. Although sensitive to chemotherapy, early relapse is common, and a predilection for visceral metastasis, including brain metastasis, has been described. Gene-expression profiling approaches demonstrated that triple negative breast cancer is a heterogeneous group of diseases composed of different, molecularly distinct subtypes. Although not synonymous, the majority of triple negative breast cancers carry the "basal-like" molecular profile on gene-expression arrays. However, several studies have shown that triple negative breast cancer includes tumors with a non-basal expression profile and, in particular, the "normal-breast," the "multiple marker negative," and the recently identified "claudin-negative" subtypes. Target-based agents, including epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and poly-ADP-ribose polymerase (PARP) inhibitors, are currently in clinical trials and hold promise in the treatment of this aggressive disease.
-
Kim Elizabeth M.H., Mueller Kelly, Gartner Elaina, Boerner Julie, Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells, Journal of Surgical Research, 185, 1, 2013. Crossref
-
Normanno Nicola, Rachiglio Anna Maria, Roma Cristin, Fenizia Francesca, Esposito Claudia, Pasquale Raffaella, La Porta Maria Libera, Iannaccone Alessia, Micheli Filippo, Santangelo Michele, Bergantino Francesca, Costantini Susan, De Luca Antonella, Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities, Journal of Cellular Biochemistry, 114, 3, 2013. Crossref
-
Mathe Andrea, Wong-Brown Michelle, Morten Brianna, Forbes John F., Braye Stephen G., Avery-Kiejda Kelly A., Scott Rodney J., Novel genes associated with lymph node metastasis in triple negative breast cancer, Scientific Reports, 5, 1, 2015. Crossref
-
Mella Mikko, Kauppila Joonas H, Karihtala Peeter, Lehenkari Petri, Jukkola-Vuorinen Arja, Soini Ylermi, Auvinen Päivi, Vaarala Markku H, Ronkainen Hanna, Kauppila Saila, Haapasaari Kirsi-Maria, Vuopala Katri S, Selander Katri S, Tumor infiltrating CD8+T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma, OncoImmunology, 4, 6, 2015. Crossref
-
Turksen Kursad, Claudins and Cancer Stem Cells, Stem Cell Reviews and Reports, 7, 4, 2011. Crossref
-
Srinivasaraghavan Vaishnavi, Strobl Jeannine, Agah Masoud, Microelectrode bioimpedance analysis distinguishes basal and claudin-low subtypes of triple negative breast cancer cells, Biomedical Microdevices, 17, 4, 2015. Crossref
-
Subramaniam Venkateswaran, Ace Olga, Prud'homme Gerald J., Jothy Serge, Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells, Experimental and Molecular Pathology, 90, 1, 2011. Crossref
-
Cheng Shi-Yann, Yang Yao-Chih, Ting Kuan-lun, Wen Su-Ying, Viswanadha Vijaya Padma, Huang Chih-Yang, Kuo Wei-Wen, Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer, Environmental Toxicology, 32, 4, 2017. Crossref
-
Mathe Andrea, Wong-Brown Michelle, Locke Warwick J., Stirzaker Clare, Braye Stephen G., Forbes John F., Clark Susan J., Avery-Kiejda Kelly A., Scott Rodney J., DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients, Scientific Reports, 6, 1, 2016. Crossref
-
Chandler Madison R., Keene Kimberly S., Tuomela Johanna M., Forero-Torres Andres, Desmond Renee, Vuopala Katri S., Harris Kevin W., Merner Nancy D., Selander Katri S., Ahmad Aamir, Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans, PLOS ONE, 12, 9, 2017. Crossref
-
Chen Yu-Hsiang, Hancock Bradley A., Solzak Jeffrey P., Brinza Dumitru, Scafe Charles, Miller Kathy D., Radovich Milan, Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy, npj Breast Cancer, 3, 1, 2017. Crossref
-
Salek Roham, Varshoee Tabrizi Fatemeh, Ghaffarzadegan Kamran, Sabouri Golnaz, Fanipakdel Azar, A Survey in the Basal Like Breast Carcinoma Phenotype in North East of Iran, Iranian Journal of Cancer Prevention, In Press, In Press, 2017. Crossref
-
Conti Laura, Lanzardo Stefania, Arigoni Maddalena, Antonazzo Roberta, Radaelli Enrico, Cantarella Daniela, Calogero Raffaele A., Cavallo Federica, The noninflammatory role of high mobility group box 1/toll‐like receptor 2 axis in the self‐renewal of mammary cancer stem cells, The FASEB Journal, 27, 12, 2013. Crossref
-
Al-Mahmood Sumayah, Sapiezynski Justin, Garbuzenko Olga B., Minko Tamara, Metastatic and triple-negative breast cancer: challenges and treatment options, Drug Delivery and Translational Research, 8, 5, 2018. Crossref
-
TUOMELA JOHANNA, SANDHOLM JOUKO, KAUPPILA JOONAS H., LEHENKARI PETRI, HARRIS KEVIN W., SELANDER KATRI S., Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer, Oncology Letters, 6, 6, 2013. Crossref
-
Avraham Hava Karsenty, Jiang Shuxian, Wang Lili, Fu Yigong, Avraham Shalom, Cellular and Molecular Mechanisms Involved in Breaching of the Blood–Brian Barrier by Circulating Breast Cancer Cells, in Breast Cancer Metastasis and Drug Resistance, 2013. Crossref
-
韩 建冬, Application of Biomarkers for Common Cancers in Molecular Diagnosis, Medical Diagnosis, 09, 01, 2019. Crossref
-
Bermejo Justo L, Huang Guanmengqian, Manoochehri Mehdi, Mesa Karen G, Schick Matthias, Silos Rosa G, Ko Yon-Dschun, Brüning Thomas, Brauch Hiltrud, Lo Wing-Yee, Hoheisel Jörg D, Hamann Ute, Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer, Epigenomics, 11, 1, 2019. Crossref